Delivery Order SPE2DB22D2211-SPE2DB25FSCND
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $1,001.38 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector, 2-pack on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The auto-injector represents a critical medical supply component...
- The Defense Logistics Agency awarded a $1,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,645.42 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $2,872.22 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Epinephrine 0.3 mg auto-injectors (2-pack). This non-set-aside, firm fixed-price contract represents a single delivery order with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order valued at $1,313.78 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector (two-pack) on July 29, 2025, with completion expected by July 30, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,128.69. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.66 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCNDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,501.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will fulfill this medical supply requirement as part of its ongoing support to the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/8/25 |